Agenda Sessions

October 26, 2009

7:00 a.m. - Registration opens

8:00 a.m. - 9:25 a.m.Breakfast Plenary

The Sell-Side's Outlook On The Life Sciences Industry And The Recovering Capital Markets In 2010

A panel of life science sell-siders will discuss their views on evolving biotech and medical device business models, liquidity events and what it will take to succeed in this financial environment.

Panelists:
Jason Kantor, Analyst, RBC Capital Markets (U.S.)
Dan Owczarski, Director & Senior Research Analyst - Health Care, Avondale Partners, LLC
Juan Sanchez, Senior Research Analyst, Ladenberg Thalmann & Co. Inc.
Andrew Vaino, Senior Research Analyst, Roth Capital Partners, LLC

Moderator:
Don Williams, Partner in Charge, Grant Thortnton

8:00 a.m. - 5:00 p.m.Partnering One x Ones

9:30 a.m. - 12:30 p.m.Company Presentations

12:30 p.m. - 1:45 p.m.Lunch - Keynote Presentation

Keynote Speaker:

Fred Frank, Vice Chairman, Peter J. Solomon Company

2:00 p.m. - 5:30 p.m.Company Presentations

5:30 p.m. - 7:00 p.m.Networking Reception

October 27, 2009

8:00 a.m. - 9:25 a.m.Breakfast Plenary

Looking Forward - A Buyside View of the Biotech Industry in 2010
A panel of experienced biotechnology and medical device industry investors and observers will discuss the key issues shaping the industry on this side of the recession.

Panelists:
Michael Dachaot, Portfolio Manager, RCM Capital Management, LLC
FaribaGhodsian, Chief Investment Officer, DAFNA Capital Management, LLC
Jon Plexico, Stone Pine Capital

Moderator:
Matthew T. Browne Partner Cooley Godward Kronish LLP

8:00 a.m. - 5:00 p.m.Partnering One x Ones

9:30 a.m. - 3:30 p.m.Company Presentations

Box lunches provided during presentations

3:30 p.m. - 5:00 p.m.Closing Plenary

So, You Have Raised A Lot Of Money -- What Impact Will This Have On The CEO Of An Emerging Life Science Company?
Venture capitalists from organizations that have raised significant funds in the last 12-18 months will discuss how they will put all of that capital to work for their investors and how the recent economic crisis will shape the life science industry going forward.

Moderator:
Mark Heesen, President, National Venture Capital Association (NVCA)

Panelists:
Dennis Purcell, Senior Managing Partner, Aisling Capital
Chris Ehrlich, General Partner, InterWest Partners
Kim Kamdar, Principal, Domain Associates LLC
Lisa Riccciardi, Adjunct Partner, Essex Woodlands Health Ventures
Bob More, General Partner, Frazier Healthcare Ventures